search
Back to results

Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the Context of Meal and Exercise Timing (TIMEX)

Primary Purpose

Overweight and Obesity, Type 2 Diabetes

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Exercise
Control
Sponsored by
Steno Diabetes Center Copenhagen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Overweight and Obesity focused on measuring Overweight, Obesity, Timing, Acute exercise, Circadian rythm, Appetite, Type 2 diabetes, Metabolism

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Adults with overweight or obesity (BMI >25 kg/m2) with and without T2D HbA1c ≥48 mmol/mol for people with T2D Exclusion Criteria: Not able to eat ad libitum meal Not able to perform the exercise bout Daily smoking For women: Pregnancy / planned pregnancy (within the study period) / lactating Self-reported history of an eating disorder in the past 3 years Self-reported weight change (>5 kg) within three months prior to inclusion Treatment with antidepressants Treatment with fast acting insulin, combination insulin products and sulfonylureas Alcohol/drug abuse or in treatment with disulfiram (antabus) at time of inclusion Uncontrolled medical issues including but not limited to cardiovascular pulmonary, rheumatologic, hematologic, oncologic, infectious, gastrointestinal, or psychiatric disease; diabetes or other endocrine disease; immunosuppression Current treatment with medication which significantly affect appetite or energy balance (e.g., GLP-1 receptor agonists) Bariatric surgery Unable to understand the informed consent and the study procedures Concomitant participation in intervention studies Incapable of understanding Danish

Sites / Locations

  • Steno Diabetes Center CopenhagenRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

Morning exercise

Morning control

Evening exercise

Evening control

Arm Description

Study visit performed in the morning with 45 min exercise.

Study visit performed in the morning with 45 min rest period.

Study visit performed in the evening with 45 min exercise.

Study visit performed in the evening with 45 min rest period.

Outcomes

Primary Outcome Measures

Ad libitum energy intake (KJ) after exercise compared with rest
Food intake (KJ) is measured after meal completion, exercise compared with rest

Secondary Outcome Measures

Ad libitum energy intake (KJ) after exercise in the morning compared with evening
Assess whether energy intake during an ad libitum meal after exercise differs between morning and evening
Ad libitum energy intake (KJ) after rest in the morning compared with evening
Assess whether energy intake during an ad libitum meal after rest differs between morning and evening
Eating pace (KJ/min)
Energy intake relative to duration of meal consumption
Glucose (mmol/L)
Concentrations of glucose
Triglyceride (mmol/L)
Concentrations of triglyceride
Total cholesterol (mmol/L)
Concentrations of total cholesterol
LDL cholesterol (mmol/L)
Concentrations of LDL cholesterol
HDL cholesterol (mmol/L)
Concentrations of HDL cholesterol
VLDL cholesterol (mmol/L)
Concentrations of VLDL cholesterol
Free-Fatty Acids (mmol/L)
Concentrations of Free-Fatty Acids.
Circulating metabolides (metabolomics) (g/mL)
Concentrations of circulating metabolides measured with metabolomic analysis
Circulating lipids (lipidomics) (g/mL)
Concentrations of circulating lipids measured with lipidomic analysis
Circulating proteins (proteomics) (g/mL)
Concentrations of circulating proteins measured with proteomic analysis
Insulin (pmol/L)
Concentrations of insulin
Glucagon (pmol/L)
Concentrations of glucagon
Total ghrelin (pmol/L)
Concentrations of total ghrelin
Acylated ghrelin (pmol/L)
Concentrations of acylated ghrelin
Glucagon-Like Peptide-1 (GLP-1) (pmol/L)
Concentrations of Glucagon-Like Peptide-1 (GLP-1)
Glucose-Dependent Insulinotropic polypeptide (GIP) (pmol/L)
Concentrations of Glucose-Dependent Insulinotropic polypeptide (GIP)
C-peptide (pmol/L)
Concentrations of C-peptide
Peptide YY (PYY) (pmol/L)
Concentrations of Peptide YY (PYY)
Peptide YY (PYY) 3-36 (pmol/L)
Concentrations of Peptide YY (PYY) 3-36
Fibroblast Growth Factor 21 (FGF-21) (pmol/L)
Concentrations of Fibroblast Growth Factor 21 (FGF-21)
Leptin (pmol/L)
Concentrations of Leptin
Growth Differentiation Factor 15 (GDF-15) (pmol/L)
Concentrations of Growth Differentiation Factor 15 (GDF-15)
Cholecystokinin (CCK) (pmol/L)
Concentrations of Cholecystokinin (CCK)
Pancreatic polypeptide (PP) (pmol/L)
Concentrations of Pancreatic polypeptide (PP)
C-reactive protein (CRP) (pmol(L)
Concentrations of C-reactive protein (CRP)
Food choice
Food choice of food items from four combined food categories (high-fat savoury, high-fat sweet, low-fat savoury and low-fat sweet foods) examined from the SBFPT. Food choice is determined based on frequency of selection made within each food category. The scores range from 0-48 i.e. 0 = foods within a specific food category have not been selected at all to 48 = foods within a specific food category have been selected 48 times.
Attention
Measured using eye tracking in response to looking at food pictures during the computerized Leeds Food Preference Questionnaire. Includes the following parameters: Gaze: Time spent (ms and %) and revisits (n); and fixations: Time to first fixation (ms), time spent (ms and %), fixation count (n), first fixation duration (ms), average fixation duration (ms). Distance to screen (mm), and gaze direction bias (ratio) which is calculated as the number of trials in which the first fixation was directed to a food image as a proportion to all trials. A bias score ˃0.5 indicates attention towards one food image, a bias score equal to 0.5 indicates no bias, and a bias score <0.5 indicates attention towards the other food images.
Reaction time (ms)
Reaction time during forced food choice of food items from four combined food categories (high-fat savoury, high-fat sweet, low-fat savoury and low-fat sweet foods) examined from the computerized Leeds Food Preference Questionnaire.
Explicit liking
Explicit liking of 16 food items from four combined food categories (high-fat savoury, high-fat sweet, low-fat savoury and low-fat sweet foods) examined from the SBFPT. Explicit liking is rated using visual analogue scales and the range is 0-100. Each end represents the extremes e.g. Question: "how pleasant would it be to taste this food right now?" Answer: "not at all" (rated 0 on the 0-100 scale) to "extremely" (rated 100 on the 0-100 scale).
Implicit wanting
Implicit wanting of food items from four combined food categories (high-fat savoury, high-fat sweet, low-fat savoury and low-fat sweet foods) examined from the SBFPT. Implicit wanting is assessed based on food choice and response time for selected and non-selected food items as well as mean response time (a frequency-weighted algorithm). In this frequency-weighted algorithm a positive score indicates a more rapid preference for a food type over another food type and a negative score indicates the opposite. A score of zero indicates that food types are equally preferred. The frequency weighted algorithm is used so the implicit wanting score is influenced by both selection (positively contributing to the score) and non-selection (negatively contributing to the score) of food type. Scores for implicit wanting typically range from -100-100 (due to reaction time there is no fixed min-max value)
Explicit wanting
Explicit wanting of 16 food items from four combined food categories (high-fat savoury, high-fat sweet, low-fat savoury and low-fat sweet foods) examined from the SBFPT. Explicit wanting is rated using visual analogue scales and the range is 0-100. Each end represents the extremes e.g. Question: "how much do you want some of this food now?" Answer: "not at all" (rated 0 on the 0-100 scale) to "extremely" (rated 100 on the 0-100 scale).
Subjective appetite
Rated using visual analogue scales and includes sensations of: Hunger, fullness, satiety, prospective food consumption, wellbeing, nausea, thirst, desire to eat meat, salty, and sweet. The scale range is 0-100 and each end represent the extremes e.g. hunger rating: "I am not hungry at all" to "I have never been this hungry before".
Energy intake (KJ)
Assessed from diet records
Borg RPE
Subjective rating of the level of exertion during exercise is collected through the Borg Rating of Percieved Exertion (RPE) at baseline and post exercise, and compared between visits.

Full Information

First Posted
February 15, 2023
Last Updated
March 30, 2023
Sponsor
Steno Diabetes Center Copenhagen
Collaborators
University of Leeds, Novo Nordisk A/S
search

1. Study Identification

Unique Protocol Identification Number
NCT05768958
Brief Title
Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the Context of Meal and Exercise Timing
Acronym
TIMEX
Official Title
Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the Context of Meal and Exercise Timing
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 22, 2023 (Actual)
Primary Completion Date
June 1, 2024 (Anticipated)
Study Completion Date
July 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Steno Diabetes Center Copenhagen
Collaborators
University of Leeds, Novo Nordisk A/S

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The overall aim is to investigate effects of acute exercise on ad libitum energy intake and study whether this differs between morning and evening in individuals with overweight/obesity with or without type 2 diabetes (T2D). Furthermore, the aim is to examine the role of hedonic and homeostatic drivers of appetite control in obesity and T2D in the context of meal and exercise timing.
Detailed Description
Fifty-eight adults (age 18 - 75 years old) with overweight/obesity (BMI >25 kg/m2) and with/without T2D will participate in this randomized cross-over study. Participants will complete two visits in the morning and two in the evening with a minimum of 3 days washout. The visits will include ratings of subjective appetite and blood samples in the fasted state followed by either a 45 min exercise bout or rest for the same duration. 15 min after the termination of the exercise bout/rest period the participants will be presented with an ad libitum meal for assessment of energy intake (primary outcome). Then the participants will complete the Steno Biometric Food Preference Task (SBFPT); A computerized task measuring food choice, explicit liking, and implicit and explicit wanting with concomitant biometric measurements. Throughout the visits, subjective appetite will be rated using visual analogue scales and blood will be collected for assessment of appetite-related hormones and metabolites. (Time: -60 minutes (fasting), -45 minutes (start exercise/rest), 0 minutes (finish exercise/rest), 15 minutes (ad libitum meal), 30 minutes (finish al libitum meal), 60 minutes (end of visit) Descriptive data will be collected at a visit prior to the test days. These data include body weight (kg), Body Mass Index (BMI, kg/m2), fat mass (kg), fat free mass (kg), fat percentage (%), HbA1c (mmol/mol and %), waist circumference (cm), VO2-0peak and ECG. The participants will furthermore fill in questionnaires regarding the following: Socio-Economic Status (SES), Control Over Eating (CoEQ), Munich Chronotype Questionnaire (MCTQ), Physical Activity Questionnaires (IPAQ), Pittsburgh Sleep Quality Index (PSQI). In addition to the outcomes listed below, markers of liver function (Alanine aminotransferase (ALAT), Aspartate Transaminase (ASAT)), HbA1c, sodium, and potassium will be measured in the fasting state on the first morning visit. The specific objectives are to: Assess whether energy intake during an ad libitum meal differs after an acute bout of exercise compared to a rest condition Assess whether energy intake during an ad libitum meal after an acute bout of exercise differs between morning and evening Assess whether appetite ratings, food reward, and metabolic markers i.e., hormones and metabolites in response to an acute exercise bout and subsequent ad libitum meal differ between morning and evening Examine if the above findings differ between individuals with and without T2D Identify circulating biomarkers that can be used to stratify individuals with overweight/obesity into primary hedonic or homeostatic driven in terms of ad libitum food intake

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight and Obesity, Type 2 Diabetes
Keywords
Overweight, Obesity, Timing, Acute exercise, Circadian rythm, Appetite, Type 2 diabetes, Metabolism

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
58 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Morning exercise
Arm Type
Experimental
Arm Description
Study visit performed in the morning with 45 min exercise.
Arm Title
Morning control
Arm Type
Experimental
Arm Description
Study visit performed in the morning with 45 min rest period.
Arm Title
Evening exercise
Arm Type
Experimental
Arm Description
Study visit performed in the evening with 45 min exercise.
Arm Title
Evening control
Arm Type
Experimental
Arm Description
Study visit performed in the evening with 45 min rest period.
Intervention Type
Other
Intervention Name(s)
Exercise
Intervention Description
45 min exercise bout performed on bicycle ergometer. The exercise bout will consist of a 10 min warm-up period at 40 % Watt max followed by 4 cycles of 4 min at 85 % Watt max and 3 min at 50 % Watt max. A cool-down period (7 min) will be performed at 40 % Watt max.
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
45 min rest during the same time period as the exercise bout on exercise study visits.
Primary Outcome Measure Information:
Title
Ad libitum energy intake (KJ) after exercise compared with rest
Description
Food intake (KJ) is measured after meal completion, exercise compared with rest
Time Frame
Measured after meal consumption at t = 30 minutes
Secondary Outcome Measure Information:
Title
Ad libitum energy intake (KJ) after exercise in the morning compared with evening
Description
Assess whether energy intake during an ad libitum meal after exercise differs between morning and evening
Time Frame
Measured after meal consumption at t = 30 minutes
Title
Ad libitum energy intake (KJ) after rest in the morning compared with evening
Description
Assess whether energy intake during an ad libitum meal after rest differs between morning and evening
Time Frame
Measured after meal consumption at t = 30 minutes
Title
Eating pace (KJ/min)
Description
Energy intake relative to duration of meal consumption
Time Frame
Measured from start to finish of meal consumption at t = 15 minutes to end of meal, morning and evening, exercise and rest
Title
Glucose (mmol/L)
Description
Concentrations of glucose
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Triglyceride (mmol/L)
Description
Concentrations of triglyceride
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Total cholesterol (mmol/L)
Description
Concentrations of total cholesterol
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
LDL cholesterol (mmol/L)
Description
Concentrations of LDL cholesterol
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
HDL cholesterol (mmol/L)
Description
Concentrations of HDL cholesterol
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
VLDL cholesterol (mmol/L)
Description
Concentrations of VLDL cholesterol
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Free-Fatty Acids (mmol/L)
Description
Concentrations of Free-Fatty Acids.
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Circulating metabolides (metabolomics) (g/mL)
Description
Concentrations of circulating metabolides measured with metabolomic analysis
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Circulating lipids (lipidomics) (g/mL)
Description
Concentrations of circulating lipids measured with lipidomic analysis
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Circulating proteins (proteomics) (g/mL)
Description
Concentrations of circulating proteins measured with proteomic analysis
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Insulin (pmol/L)
Description
Concentrations of insulin
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Glucagon (pmol/L)
Description
Concentrations of glucagon
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Total ghrelin (pmol/L)
Description
Concentrations of total ghrelin
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Acylated ghrelin (pmol/L)
Description
Concentrations of acylated ghrelin
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Glucagon-Like Peptide-1 (GLP-1) (pmol/L)
Description
Concentrations of Glucagon-Like Peptide-1 (GLP-1)
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Glucose-Dependent Insulinotropic polypeptide (GIP) (pmol/L)
Description
Concentrations of Glucose-Dependent Insulinotropic polypeptide (GIP)
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
C-peptide (pmol/L)
Description
Concentrations of C-peptide
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Peptide YY (PYY) (pmol/L)
Description
Concentrations of Peptide YY (PYY)
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Peptide YY (PYY) 3-36 (pmol/L)
Description
Concentrations of Peptide YY (PYY) 3-36
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Fibroblast Growth Factor 21 (FGF-21) (pmol/L)
Description
Concentrations of Fibroblast Growth Factor 21 (FGF-21)
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Leptin (pmol/L)
Description
Concentrations of Leptin
Time Frame
Fasting (t = -60 minutes), and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Growth Differentiation Factor 15 (GDF-15) (pmol/L)
Description
Concentrations of Growth Differentiation Factor 15 (GDF-15)
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Cholecystokinin (CCK) (pmol/L)
Description
Concentrations of Cholecystokinin (CCK)
Time Frame
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Pancreatic polypeptide (PP) (pmol/L)
Description
Concentrations of Pancreatic polypeptide (PP)
Time Frame
Fasting (t = -60 minutes), and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
C-reactive protein (CRP) (pmol(L)
Description
Concentrations of C-reactive protein (CRP)
Time Frame
Fasting (t = -60 minutes), and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Food choice
Description
Food choice of food items from four combined food categories (high-fat savoury, high-fat sweet, low-fat savoury and low-fat sweet foods) examined from the SBFPT. Food choice is determined based on frequency of selection made within each food category. The scores range from 0-48 i.e. 0 = foods within a specific food category have not been selected at all to 48 = foods within a specific food category have been selected 48 times.
Time Frame
Measured before exercise/rest (t = -60 minutes) and after meal consumption (t= 30 minutes), morning and evening, exercise and rest
Title
Attention
Description
Measured using eye tracking in response to looking at food pictures during the computerized Leeds Food Preference Questionnaire. Includes the following parameters: Gaze: Time spent (ms and %) and revisits (n); and fixations: Time to first fixation (ms), time spent (ms and %), fixation count (n), first fixation duration (ms), average fixation duration (ms). Distance to screen (mm), and gaze direction bias (ratio) which is calculated as the number of trials in which the first fixation was directed to a food image as a proportion to all trials. A bias score ˃0.5 indicates attention towards one food image, a bias score equal to 0.5 indicates no bias, and a bias score <0.5 indicates attention towards the other food images.
Time Frame
Measured before exercise/rest (t = -60 minutes) and after meal consumption (t= 30 minutes), morning and evening, exercise and rest
Title
Reaction time (ms)
Description
Reaction time during forced food choice of food items from four combined food categories (high-fat savoury, high-fat sweet, low-fat savoury and low-fat sweet foods) examined from the computerized Leeds Food Preference Questionnaire.
Time Frame
Measured before exercise/rest (t = -60 minutes) and after meal consumption (t= 30 minutes), morning and evening, exercise and rest
Title
Explicit liking
Description
Explicit liking of 16 food items from four combined food categories (high-fat savoury, high-fat sweet, low-fat savoury and low-fat sweet foods) examined from the SBFPT. Explicit liking is rated using visual analogue scales and the range is 0-100. Each end represents the extremes e.g. Question: "how pleasant would it be to taste this food right now?" Answer: "not at all" (rated 0 on the 0-100 scale) to "extremely" (rated 100 on the 0-100 scale).
Time Frame
Measured before exercise/rest (t = -60 minutes) and after meal consumption (t= 30 minutes), morning and evening, exercise and rest
Title
Implicit wanting
Description
Implicit wanting of food items from four combined food categories (high-fat savoury, high-fat sweet, low-fat savoury and low-fat sweet foods) examined from the SBFPT. Implicit wanting is assessed based on food choice and response time for selected and non-selected food items as well as mean response time (a frequency-weighted algorithm). In this frequency-weighted algorithm a positive score indicates a more rapid preference for a food type over another food type and a negative score indicates the opposite. A score of zero indicates that food types are equally preferred. The frequency weighted algorithm is used so the implicit wanting score is influenced by both selection (positively contributing to the score) and non-selection (negatively contributing to the score) of food type. Scores for implicit wanting typically range from -100-100 (due to reaction time there is no fixed min-max value)
Time Frame
Measured before exercise/rest (t = -60 minutes) and after meal consumption (t= 30 minutes), morning and evening, exercise and rest
Title
Explicit wanting
Description
Explicit wanting of 16 food items from four combined food categories (high-fat savoury, high-fat sweet, low-fat savoury and low-fat sweet foods) examined from the SBFPT. Explicit wanting is rated using visual analogue scales and the range is 0-100. Each end represents the extremes e.g. Question: "how much do you want some of this food now?" Answer: "not at all" (rated 0 on the 0-100 scale) to "extremely" (rated 100 on the 0-100 scale).
Time Frame
Measured before exercise/rest (t = -60 minutes) and after meal consumption (t= 30 minutes), morning and evening, exercise and rest
Title
Subjective appetite
Description
Rated using visual analogue scales and includes sensations of: Hunger, fullness, satiety, prospective food consumption, wellbeing, nausea, thirst, desire to eat meat, salty, and sweet. The scale range is 0-100 and each end represent the extremes e.g. hunger rating: "I am not hungry at all" to "I have never been this hungry before".
Time Frame
Fasting (t = -60, 0 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Title
Energy intake (KJ)
Description
Assessed from diet records
Time Frame
Registered 24 hours after the test days, morning and evening, exercise and rest
Title
Borg RPE
Description
Subjective rating of the level of exertion during exercise is collected through the Borg Rating of Percieved Exertion (RPE) at baseline and post exercise, and compared between visits.
Time Frame
Measured after exercise (t = 0 minutes) , morning and evening

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adults with overweight or obesity (BMI >25 kg/m2) with and without T2D HbA1c ≥48 mmol/mol for people with T2D Exclusion Criteria: Not able to eat ad libitum meal Not able to perform the exercise bout Daily smoking For women: Pregnancy / planned pregnancy (within the study period) / lactating Self-reported history of an eating disorder in the past 3 years Self-reported weight change (>5 kg) within three months prior to inclusion Treatment with antidepressants Treatment with fast acting insulin, combination insulin products and sulfonylureas Alcohol/drug abuse or in treatment with disulfiram (antabus) at time of inclusion Uncontrolled medical issues including but not limited to cardiovascular pulmonary, rheumatologic, hematologic, oncologic, infectious, gastrointestinal, or psychiatric disease; diabetes or other endocrine disease; immunosuppression Current treatment with medication which significantly affect appetite or energy balance (e.g., GLP-1 receptor agonists) Bariatric surgery Unable to understand the informed consent and the study procedures Concomitant participation in intervention studies Incapable of understanding Danish
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kristine Færch, PhD
Phone
+45 30913061
Email
kristine.faerch@regionh.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Jonas S Quist, PhD
Phone
+45 26176064
Email
jonas.salling.quist@regionh.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kristine Færch, PhD
Organizational Affiliation
Steno Diabetes Center Copenhagen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Steno Diabetes Center Copenhagen
City
Herlev
ZIP/Postal Code
DK-2730
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kristine Færch, PhD
Phone
+4530913061
Email
kristine.faerch@regionh.dk
First Name & Middle Initial & Last Name & Degree
Jonas S Quist, PhD
Phone
+26176064
Email
jonas.salling.quist@regionh.dk

12. IPD Sharing Statement

Learn more about this trial

Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the Context of Meal and Exercise Timing

We'll reach out to this number within 24 hrs